United States Drug Enforcement Administration

WASHINGTON – The U.S. Drug Enforcement Administration has seen an increase in burglaries at independent pharmacies across the country. Nearly 900 burglaries involving the theft of controlled substances were reported to DEA in 2023. Stolen prescription medications adversely impact these small businesses while also putting patients and the community at...

WASHINGTON, D.C. – The U.S. Drug Enforcement Administration announced today a settlement with pharmaceutical distributor Morris & Dickson Co., LLC for failing to maintain effective controls against diversion of controlled substances, including failure to report to DEA thousands of unusually large orders of oxycodone and hydrocodone. Morris & Dickson, which...

WASHINGTON – Today, the U.S. Drug Enforcement Administration announced administrative actions against six DEA-registered companies which, together, failed to account for more than a million doses of opioids. Under DEA initiative “Operation Bottleneck,” DEA served an Immediate Suspension Order and five Orders to Show Cause over a one-month period from...

WASHINGTON – Today, ahead of the expiration of the COVID-19 Public Health Emergency (PHE), the Drug Enforcement Administration (DEA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) issued the “Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications” – a temporary rule that extends telemedicine flexibilities...

WASHINGTON - Today, the Drug Enforcement Administration announced proposed permanent rules for the prescribing of controlled medications via telemedicine, expanding patient access to critical therapies beyond the scheduled end of the COVID-19 public health emergency. The public will be able to comment for 30 days on the proposed rules. The...

WASHINGTON -- Today, DEA served an Order to Show Cause on Truepill, a retail pharmacy that is alleged to have wrongfully filled thousands of prescriptions for stimulants used in the treatment of Attention Deficit/Hyperactivity Disorder (ADHD). Truepill was the pharmacy for telehealth companies, including Cerebral, that marketed ADHD treatments, including...

Houston-A federal jury in the Southern District of Texas convicted a Texas pharmacy owner yesterday for unlawfully distributing controlled substances and laundering money from his now-shuttered pharmacies. According to court documents and evidence presented at trial, Clint Carr, 32, of Cypress, co-owned and operated CC Pharmacy in Houston, and CC...

HOUSTON, TX – Today, Drug Enforcement Administration Houston Division diversion investigators served an Immediate Suspension Order (ISO) that immediately suspended the DEA registration held by Wholesale Rx also known as “Tyler Pharmaceuticals” located in Cordova, TN. Wholesale Rx is suspected of diverting controlled substances onto the black market resulting in...

BEAUMONT, Texas – A federal grand jury in Beaumont has returned a three-count indictment charging a Florida resident, along with nine other individuals, in a drug trafficking conspiracy in the Eastern District of Texas, announced Drug Enforcement Administration (DEA) Special Agent in Charge Daniel C. Comeaux, Houston Division and U.S...

AUSTIN – Today 13 individuals were arrested on criminal charges for their alleged involvement in fentanyl distribution announced Drug Enforcement Administration (DEA) Special Agent in Charge Daniel C. Comeaux and United States Attorney Ashley C. Hoff. According to court documents, Marcos Garcia, 18, of Somerton, AZ; Oliver Garcia, 20, of...